Search Results for "Drugs From Pharmacia Corporation"

05:07 EST 31st January 2015 | BioPortfolio

Matching Channels

Matching News

Genex Corp. sells Protein G business to Pharmacia LKB Biotech

Genex Corporation (specialty pharmaceuticals) sold its Protein G business, used in affinity chromatography, to Pharmacia LKB Biotechnology for approximately $2 million.

Enclara Health and Hospice Pharmacia Unveil Updated Name and Logo at National Hospice and Palliative Care Conference

Executives Present on Guidance and Support for Hospices under CMS' Updated Medicare D Rules. NASHVILLE, TN (PRWEB) October 28, 2014 Enclara Health, LLC and its recently acquired affiliate excelle...

Drugmakers “outraged” at UK Cancer Drugs Fund decision to remove drugs from coverage

The UK’s Cancer Drugs Fund is overspent and 42 drugs are being reassessed as price caps are brought in for the first time. NHS England said the current system was unsustainable and that there were n...

Hospice of Michigan Partners with Enclara Health and Hospice Pharmacia to Provide Pharmacy Services for Hospice Patients

As the hospice market evolves, Enclara Health and Hospice Pharmacia continue to develop solution-focused programs PHILADELPHIA, PA and DETROIT, MI (PRWEB) September 05, 2014 Enclara Health and Hospic...

UK Cancer Drugs Fund to re-assess procedure and currently-approved drugs

The UK’s National Health Service has updated its procedure for evaluating drugs in the Cancer Drugs Fund, which it says means more effective and promising drugs will be prioritized and made availabl...

Drugmakers “outraged” at England's Cancer Drugs Fund decision to remove drugs from coverage

England’s Cancer Drugs Fund is overspent and 42 drugs are being reassessed as price caps are brought in for the first time. NHS England said the current system was unsustainable and that there were ...

Generic Drugs Undergo Rigorous FDA Scrutiny

How does FDA ensure that generic prescription drugs are safe and effective alternatives to brand-name drugs? The generic drugs approval process includes a review of scientific data on manufacturing, i...

Cancer Drugs Fund table: 12 drugs delisted, six refused entry

England's latest Cancer Drugs Fund decisions, which follow a recent overhaul of the assessment process, have resulted in 12 previously funded drugs being withdrawn in 24 indications, and six drugs app...

Matching PubMed Articles

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012.

Innovative new drugs offer potential benefits to patients, healthcare systems, governments and the pharmaceutical industry. Recent data suggest annual numbers of new drugs launched in the UK have incr...

Reactive Oxygen Species and Autophagy Modulation in Non-Marine Drugs and Marine Drugs.

It is becoming more understandable that an existing challenge for translational research is the development of pharmaceuticals that appropriately target reactive oxygen species (ROS)-mediated molecula...

Changing the times of administration of controlled drugs reduces errors.

An innovative new palliative care unit opened in December 2011 within an NHS hospital with a completely new team, many of whom had not worked in a predominantly palliative setting before. A high volum...

Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.

Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic drugs, however, low-potency antipsychotic drugs a...

Dyspnea and Reversibility Profile of P2Y12 Antagonists: Systematic Review of New Antiplatelet Drugs.

Dyspnea has been consecutively reported in some trials evaluating new P2Y12 inhibitors.

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement